These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7321057)

  • 1. Structural analysis of fibronectin with monoclonal antibodies.
    Atherton BT; Taylor DM; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(2):153-61. PubMed ID: 7321057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the structural and functional properties of fibronectin--a high molecular weight plasma glycoproteins--by using monoclonal antibodies].
    Chernousov MA; Metsis ML; Glukhova MA; Antonov AS; Orekhov AN
    Mol Biol (Mosk); 1984; 18(3):643-52. PubMed ID: 6206390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A difference between plasma and cellular fibronectins located with monoclonal antibodies.
    Atherton BT; Hynes RO
    Cell; 1981 Jul; 25(1):133-41. PubMed ID: 6168385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies that distinguish between human cellular and plasma fibronectin.
    Keen J; Chang SE; Taylor-Papadimitriou J
    Mol Biol Med; 1984 Feb; 2(1):15-27. PubMed ID: 6083431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells.
    Mohri H; Katoh K; Iwamatsu A; Okubo T
    Exp Cell Res; 1996 Feb; 222(2):326-32. PubMed ID: 8598221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells.
    Kato K; Mohri H; Tamura T; Okubo T
    Biochem Biophys Res Commun; 1997 Oct; 239(1):205-11. PubMed ID: 9345296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification with monoclonal antibodies of different regions of human plasma fibronectin, including that which interacts with human monocyte fibronectin receptors.
    Czop JK; Kadish JL; Zepf DM; Austen KF
    Immunology; 1985 Mar; 54(3):407-17. PubMed ID: 2579023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
    Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
    Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical analysis of fibronectin using monoclonal antibodies.
    Kavinsky CJ; Clark WA; Garber BB
    Biochim Biophys Acta; 1982 Aug; 705(3):330-40. PubMed ID: 6751399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule.
    Pierschbacher MD; Hayman EG; Ruoslahti E
    Cell; 1981 Oct; 26(2 Pt 2):259-67. PubMed ID: 6174240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of plasma fibronectin to Candida albicans occurs through the cell binding domain.
    Penn C; Klotz SA
    Microb Pathog; 1994 Dec; 17(6):387-93. PubMed ID: 7752880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them.
    Vartio T; Barlati S; de Petro G; Miggiano V; Stähli C; Takács B; Vaheri A
    Eur J Biochem; 1983 Sep; 135(2):203-7. PubMed ID: 6884362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies.
    Smith DE; Furcht LT
    J Biol Chem; 1982 Jun; 257(11):6518-23. PubMed ID: 6176583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies directed to two different domains of human plasma fibronectin: their specificities.
    Sekiguchi K; Patterson CM; Ishigami F; Hakomori S
    FEBS Lett; 1982 Jun; 142(2):243-6. PubMed ID: 7106289
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin.
    Dardik R; Lahav J
    Exp Cell Res; 1999 May; 248(2):407-14. PubMed ID: 10222132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies used as probes for the structural organization of the central region of fibronectin.
    Dziadek M; Richter H; Schachner M; Timpl R
    FEBS Lett; 1983 May; 155(2):321-5. PubMed ID: 6189741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of bacterial-binding property in the type III repeat domain of fibronectin.
    Ito HO; Soutome S; Nokihara K; Inoue M
    Biochem Biophys Res Commun; 2004 Jul; 320(2):347-53. PubMed ID: 15219833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.